Clinical Study

HLA Markers for Poor Prognosis in Systemic Sclerosis Brazilian Patients

Table 5

Risk and protective alleles for pulmonary arterial hypertension.

PAH-related allelesPR(95% CI)

HLA-B*352.58(1.14–5.85)0.035
HLA-C*042.71(1.19–6.18)0.015
HLA-C*030.13(0.01–2.14)0.044

95% CI: 95% confidence intervals; PR: prevalence ratio; *univariate values calculated with Chi-square and Fisher’s exact tests where appropriate.
The PR and values were obtained by comparing patients with and without PF and PAH.